Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Frontiers in Endocrinology
|
May 31, 2021
Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
Neil Tanday, Andrew English, Ryan A Lafferty, et al.
Biofactors (Oxford, England)
|
April 18, 2024
Novel enzyme-resistant pancreatic polypeptide analogs evoke pancreatic beta-cell rest, enhance islet cell turnover, and inhibit food intake in mice
Wuyun Zhu, Neil Tanday, Ryan A Lafferty, et al.
Peptides
|
February 24, 2022
Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
Shruti Mohan, Ryan A Lafferty, Peter R Flatt, et al.
Biochemical Pharmacology
|
December 29, 2022
Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice
Andrew G McCloskey, Michael G Miskelly, Ryan A Lafferty, et al.
Frontiers in Endocrinology
|
June 7, 2021
Proglucagon-Derived Peptides as Therapeutics
Ryan A Lafferty, Finbarr P M O'Harte, Nigel Irwin, et al.
The Journal of Pharmacy and Pharmacology
|
October 7, 2022
Effects of artemether on pancreatic islet morphology, islet cell turnover and α-cell transdifferentiation in insulin-deficient GluCreERT2;ROSA26-eYFP diabetic mice
Dipak Sarnobat, Ryan A Lafferty, R Charlotte Moffett, et al.
Diabetes, Obesity & Metabolism
|
November 7, 2019
Peptide YY (1-36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survival
Ryan A Lafferty, Neil Tanday, Andrew McCloskey, et al.
The Journal of Endocrinology
|
August 25, 2022
Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice
Ryan A Lafferty, Laura M McShane, Zara J Franklin, et al.
Frontiers in Endocrinology
|
March 15, 2021
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
Ryan A Lafferty, Neil Tanday, R Charlotte Moffett, et al.
Biochimie
|
April 19, 2022
Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed mice
Zara J Franklin, Ryan A Lafferty, Peter R Flatt, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Frontiers in Endocrinology
|
May 31, 2021
Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
Neil Tanday, Andrew English, Ryan A Lafferty, et al.
Biofactors (Oxford, England)
|
April 18, 2024
Novel enzyme-resistant pancreatic polypeptide analogs evoke pancreatic beta-cell rest, enhance islet cell turnover, and inhibit food intake in mice
Wuyun Zhu, Neil Tanday, Ryan A Lafferty, et al.
Peptides
|
February 24, 2022
Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
Shruti Mohan, Ryan A Lafferty, Peter R Flatt, et al.
Biochemical Pharmacology
|
December 29, 2022
Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice
Andrew G McCloskey, Michael G Miskelly, Ryan A Lafferty, et al.
Frontiers in Endocrinology
|
June 7, 2021
Proglucagon-Derived Peptides as Therapeutics
Ryan A Lafferty, Finbarr P M O'Harte, Nigel Irwin, et al.
The Journal of Pharmacy and Pharmacology
|
October 7, 2022
Effects of artemether on pancreatic islet morphology, islet cell turnover and α-cell transdifferentiation in insulin-deficient GluCreERT2;ROSA26-eYFP diabetic mice
Dipak Sarnobat, Ryan A Lafferty, R Charlotte Moffett, et al.
Diabetes, Obesity & Metabolism
|
November 7, 2019
Peptide YY (1-36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survival
Ryan A Lafferty, Neil Tanday, Andrew McCloskey, et al.
The Journal of Endocrinology
|
August 25, 2022
Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice
Ryan A Lafferty, Laura M McShane, Zara J Franklin, et al.
Frontiers in Endocrinology
|
March 15, 2021
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
Ryan A Lafferty, Neil Tanday, R Charlotte Moffett, et al.
Biochimie
|
April 19, 2022
Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed mice
Zara J Franklin, Ryan A Lafferty, Peter R Flatt, et al.
Page
of 3